A protocol for computational design of mRNA vaccines with high functionality and specificity

Area of Science:

• Vaccinology
• Computational Biology
• Bioinformatics

Background:

• Effective mRNA vaccine development necessitates robust strategies for target selection, optimization, and validation.
• A standardized computational framework is crucial for streamlining the mRNA vaccine design process from gene selection to construct optimization.

Purpose of the Study:

• To establish a comprehensive, standardized computational protocol for designing mRNA vaccines.
• To integrate key design stages including epitope selection, codon optimization, and RNA structure assessment into a unified workflow.

Main Methods:

• Developed a computational framework encompassing immunoinformatics, population coverage analysis, codon adaptation index optimization, RNA secondary structure assessment, and target accessibility.
• Applied the protocol to SARS-CoV-2 spike protein, designing both coding sequence (CDS) and multi-epitope vaccine constructs (MEVC).
• Validated constructs using in silico cloning and immune simulations.

Main Results:

• The protocol successfully generated mRNA vaccine constructs with predicted high immunogenicity and broad population coverage.
• In silico validation supported the efficacy of the optimized MEVC, aligning with existing experimental data.
• The designed constructs demonstrated improved stability and translational efficiency.

Conclusions:

• The developed protocol provides a standardized computational roadmap for designing effective mRNA vaccines.
• This methodology facilitates the creation of stable, immunogenic, and translationally efficient vaccines against diverse pathogens.
• The protocol is applicable to both CDS and MEVC designs, accelerating vaccine development pipelines.